NCT04179851

Brief Summary

Assessment of the jugular venous pressure (JVP) is an important clinical sign and correlates with right atrial (RA) pressure. A patient with heart failure (HF) typically has an elevated JVP, but in cases of dehydration JVP may be low. Assessment of the JVP is key to the management of patients with fluid overload or needing diuretics. Currently the assessment of JVP is made by the physician by direct visualization of the neck veins. However this is inaccurate, may vary between investigators and depends largely on the patient's habitus. The JVP and RA pressures may also be directly measured by catheterization (a routine during right heart catheterization), but this is an invasive procedure that is seldom performed. A thermal movie of the external jugular vein at a specific neck position may help to measure the JVP. In this study different modalities of JVP assessment (clinical assessment, thermal image and invasive measurement) are to be compared Patients scheduled for right heart catheterization at the Shaare Zedek Medical Center for non-study related medical indications will be approached. Non-invasive estimates of JVP will be performed independently prior to the right heart catheterization, during the waiting period (within 2 hours) prior to catheterization. These will include up to 2min of thermal camera recording (to be analysed offline) and a physician's JVP evaluation. The angle of the patient's upper body will be 30-60°, the rotation of the neck will be optimal for filming, and the neck area may be cooled to enhance the images. Blinding to the results will be confirmed by performance with separate investigators and separate data registration. Right heart catheterization will then be performed and RA pressure will be recorded, as well as pulmonary and wedge pressures. JVP measured by physician and thermal image will be matched with invasive catheterization (the gold standard) using Bland Altman plots and Spearmann correlation and comparison between methods will be performed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 5, 2017

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

November 21, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 27, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2019

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

November 27, 2019

Status Verified

November 1, 2019

Enrollment Period

2.9 years

First QC Date

November 21, 2019

Last Update Submit

November 25, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • central venous pressure (direct and indirect evaluation)

    comparison of estimated venous pressure (in mmHg) to the direct measurement during right heart catheterization

    up to 30 days for analysis of the thermal images, up to 24hours for the direct measurement

Interventions

Thermal imaging of neck veins

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients scheduled for right heart catheterization at the Shaare Zedek Medical Center for non-study related medical indications will be approached

You may qualify if:

  • Patients already scheduled for right heart catheterization for clinical indication
  • Age 18-90

You may not qualify if:

  • Local scar wound or bruise in the right side of the neck.
  • Current upper torso central venous catheterization such as a PICC line or dialysis catheter.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shaare zedek MC

Jerusalem, Israel

RECRUITING

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Tal Hasin, MD

    SaareZMC

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Astrid Rojanski

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 21, 2019

First Posted

November 27, 2019

Study Start

February 5, 2017

Primary Completion

December 30, 2019

Study Completion

December 31, 2019

Last Updated

November 27, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

Locations